Recombinant Lysinibacillus sphaericus UPF0316 protein Bsph_0745 (Bsph_0745)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. To ensure a specific tag type, please inform us in advance; we will prioritize its implementation.
Synonyms
Bsph_0745; UPF0316 protein Bsph_0745
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-173
Protein Length
full length protein
Species
Lysinibacillus sphaericus (strain C3-41)
Target Names
Bsph_0745
Target Protein Sequence
MQSIVLILILQLVYVPFLTLRTIFLVKNITFLAAIFGMLEMLVYVFGLSLVFSGKQSMLA MVVYAVGFGLGIFLGAKIERKLAIGYVYTTINTQNKNEELVRFLRNEGFAVTIYVGEGRD SNRYKYEILTKRNRETELFQIVEQFEPNAFIISYEPKSFKGGFLLARMKAKQK
Uniprot No.

Target Background

Database Links
Protein Families
UPF0316 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the UPF0316 protein Bsph_0745 and what is known about its function in Lysinibacillus sphaericus?

Bsph_0745 is a protein of unknown function (UPF) belonging to the UPF0316 family found in Lysinibacillus sphaericus, a gram-positive, spore-forming bacterium widely used in mosquito control programs. While the specific function of Bsph_0745 remains uncharacterized, bioinformatic analyses suggest it may be involved in cellular processes related to bacterial stress response or metabolic regulation. Understanding this protein may provide insights into L. sphaericus' unique inability to metabolize carbohydrates and its highly conserved genome characteristics . Initial investigations should include sequence homology searches, structural predictions, and preliminary expression studies to establish baseline knowledge before proceeding to more advanced functional characterization.

How can I overcome transformation barriers when working with Lysinibacillus sphaericus?

Genetic manipulation of L. sphaericus presents significant challenges due to its robust restriction-modification (R-M) systems. Based on current research, two effective strategies are recommended to overcome these barriers:

  • In vitro methylation of plasmid DNA prior to electroporation. This can be achieved using either cell-free extracts (CFE) from the target L. sphaericus strain or commercial methyltransferases such as M.HaeIII. This method has shown transformation efficiencies of approximately 2 × 10^5 transformants/μg DNA in L. sphaericus C3-41 .

  • Using L. sphaericus strains with deletion of restriction endonuclease genes. For example, the Δ0498 mutant (with deletion of the lspC3-41IR gene) shows significantly improved transformation efficiency with unmethylated plasmid DNA .

It's worth noting that only three strains among 16 tested L. sphaericus strains (all belonging to serotype H5 and MLST sequence type 1) contain the LspC3-41I R-M system. Alternative approaches include using naturally transformable strains like 2297, NRS1693, and Bs-197, which are deficient in restriction enzymes .

What structural analysis techniques are most appropriate for characterizing Bsph_0745?

A multi-technique approach is recommended for comprehensive structural characterization of Bsph_0745. Begin with protein crystallography to determine the three-dimensional structure, as this provides atomic-level resolution crucial for understanding protein function. For crystallography optimization, consider screening various buffer conditions (pH 6.0-8.5), precipitants, and additives while maintaining protein concentrations of 5-20 mg/mL. If crystallization proves challenging, nuclear magnetic resonance (NMR) spectroscopy offers an alternative for proteins <25 kDa, providing information on structural dynamics in solution.

For higher-order structure analysis, small-angle X-ray scattering (SAXS) can determine the protein's shape in solution and identify potential oligomerization states. Circular dichroism (CD) spectroscopy should be employed to assess secondary structure content and thermal stability. Additionally, for Bsph_0745 specifically, hydrogen-deuterium exchange mass spectrometry (HDX-MS) might reveal conformational changes upon ligand binding, potentially identifying interaction partners. This comprehensive structural approach can provide insights into functional domains despite the current lack of annotated function for this UPF0316 family protein.

How can I design experiments to identify potential interaction partners of Bsph_0745?

To identify interaction partners of Bsph_0745, implement a multi-faceted approach combining both in vitro and in vivo techniques. Begin with affinity-based pull-down assays using recombinant His-tagged or GST-tagged Bsph_0745 as bait against L. sphaericus lysate, followed by mass spectrometry analysis of co-precipitated proteins. Validate these interactions through reciprocal co-immunoprecipitation experiments.

For in vivo confirmation, bacterial two-hybrid systems can be employed, though these may require adaptation for use in L. sphaericus. If transformation barriers exist, consider performing these experiments in more genetically tractable surrogate hosts like B. subtilis after addressing methylation requirements . Cross-linking mass spectrometry (XL-MS) provides an additional layer of validation by capturing transient interactions in their native cellular environment.

Bioinformatic approaches should complement experimental work through computational prediction of protein-protein interactions based on structural homology, co-expression patterns, and genomic context analysis. The predicted interactions should be organized in a protein interaction network to identify potential functional complexes or pathways involving Bsph_0745.

What role might Bsph_0745 play in the insecticidal properties of Lysinibacillus sphaericus?

While direct evidence for Bsph_0745's involvement in L. sphaericus' insecticidal properties remains to be established, several experimental approaches can test this hypothesis. The protein's potential role could be investigated through knockout studies followed by bioassays against mosquito larvae (particularly Anopheles and Culex species) to determine if mosquitocidal activity is affected . Given that L. sphaericus produces binary toxins (Bin), Mtx toxins, and other virulence factors that contribute to its insecticidal properties, researchers should examine whether Bsph_0745 interacts with known toxin components or influences their expression.

Comparative proteomic studies between wild-type and Bsph_0745-deficient strains during exposure to insect hemolymph could reveal differential protein expression patterns related to pathogenicity. Additionally, heterologous co-expression studies of Bsph_0745 with known toxin proteins (similar to the successful co-expression of Mtx1 and Mtx2 toxins ) might demonstrate synergistic effects on toxicity. If Bsph_0745 proves to enhance insecticidal activity, this could lead to the development of more effective biopesticides against disease vectors.

What purification strategy is optimal for obtaining high-purity recombinant Bsph_0745?

A multi-step purification protocol is recommended for high-purity Bsph_0745 preparation. Begin with affinity chromatography using a histidine tag (His6) at either the N- or C-terminus depending on structural predictions to avoid interfering with protein folding. Ni-NTA resin is preferred for initial capture, followed by imidazole gradient elution (20-250 mM) in buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, and 5% glycerol.

After affinity purification, perform intermediate purification via ion-exchange chromatography. Since the theoretical pI of Bsph_0745 can be calculated from its amino acid sequence, select either cation or anion exchange accordingly. For example, if pI < 7, use Q-Sepharose (anion exchange) at pH 8.0; if pI > 7, use SP-Sepharose (cation exchange) at pH 6.5.

For final polishing, size-exclusion chromatography using Superdex 75 or 200 columns (depending on the molecular weight of Bsph_0745) should remove aggregates and yield homogeneous protein. Throughout purification, monitor protein purity via SDS-PAGE and verify identity through Western blotting and mass spectrometry. Typical yields should range from 5-20 mg/L of bacterial culture, with >95% purity achievable through this approach.

How can I optimize expression conditions to enhance soluble Bsph_0745 yield?

Optimizing expression conditions for soluble Bsph_0745 requires systematic evaluation of multiple parameters. The following optimization matrix has proven effective for recombinant proteins from L. sphaericus:

ParameterConditions to TestNotes
Expression hostE. coli BL21(DE3), Rosetta, Arctic ExpressRosetta helpful if L. sphaericus codon bias is an issue
Growth temperature37°C, 30°C, 18°CLower temperatures typically improve solubility
Induction OD6000.4-0.6, 0.8-1.0, 1.2-1.5Mid-log phase often optimal
Inducer concentration0.1, 0.5, 1.0 mM IPTGLower concentrations may improve solubility
Expression time4h, 8h, 16h, 24hLonger times at lower temperatures often beneficial
Media compositionLB, TB, 2×YT, M9Richer media generally yields more protein
Additives5% glycerol, 0.5M sorbitol, 2% glucoseOsmolytes can stabilize nascent proteins

For each condition, evaluate both total and soluble protein fractions. If solubility remains poor, consider fusion partners such as MBP, SUMO, or TrxA. For high-throughput screening, implement a 96-well plate format with automated cell lysis and analysis by SDS-PAGE or dot blot.

Additionally, if working directly with L. sphaericus expression systems, remember that plasmid methylation or use of restriction-deficient strains is essential for successful transformation .

What in silico approaches can predict the function of Bsph_0745 given its uncharacterized status?

A comprehensive in silico approach to predict Bsph_0745 function should employ multiple complementary computational techniques. Begin with sequence-based analyses including PSI-BLAST and HHpred for sensitive detection of remote homologs, followed by multiple sequence alignment to identify conserved residues potentially important for function. Domain prediction tools like PFAM, SMART, and InterProScan may identify functional domains within the UPF0316 family.

Structure prediction using AlphaFold2 or RoseTTAFold can generate high-confidence 3D models, which can be analyzed for structural similarity to characterized proteins using DALI or TM-align. Binding site prediction tools such as 3DLigandSite or COACH may identify potential ligand-binding pockets. For proteins of unknown function, structural motifs often provide better functional clues than sequence alone.

Analysis of genomic context through examination of neighboring genes in the L. sphaericus genome might reveal functional associations. Gene co-expression networks from transcriptomic data can further suggest functional relationships. Finally, employ protein-protein interaction prediction tools like STRING and biochemical pathway analysis to place Bsph_0745 in its biological context. Integrated analysis across these approaches often provides convergent evidence for function that individual methods might miss.

How should I analyze contradictory results between in vitro and in vivo studies of Bsph_0745?

When confronted with contradictory results between in vitro and in vivo studies of Bsph_0745, employ a systematic troubleshooting approach. First, evaluate the experimental conditions: in vitro systems may lack cofactors, proper pH, or cellular partners necessary for native protein function. Document key differences in experimental parameters including buffer composition, temperature, protein concentration, and presence of binding partners.

Perform validation experiments using complementary techniques. For instance, if in vitro binding assays show interaction with a partner protein but in vivo co-immunoprecipitation does not, confirm with orthogonal methods like FRET, proximity ligation assays, or crosslinking studies. Consider the impact of protein tags, which might interfere with function in one system but not another. If using knockout studies in L. sphaericus, verify complete elimination of the protein and rule out compensatory mechanisms through transcriptomic analysis.

Examine the genetic background of the L. sphaericus strains used. Different strains have varying R-M systems and metabolic capabilities that might affect experimental outcomes. When possible, perform experiments in multiple strains to distinguish strain-specific from general effects. Finally, reconcile contradictions by developing a mechanistic model that explains both sets of observations, which may reveal regulation mechanisms or contextual dependencies of Bsph_0745 function.

What statistical approaches are most appropriate for analyzing Bsph_0745 functional assay data?

The appropriate statistical approach for analyzing Bsph_0745 functional assay data depends on the experimental design and data characteristics. For single-factor experiments comparing wild-type to mutant protein activity, begin with normality testing (Shapiro-Wilk test) to determine whether parametric (t-test, ANOVA) or non-parametric (Mann-Whitney U, Kruskal-Wallis) tests are appropriate. For multifactorial experiments investigating protein activity under various conditions, employ two-way or multiway ANOVA with appropriate post-hoc tests (Tukey's HSD for all pairwise comparisons or Dunnett's test when comparing to a control).

For dose-response relationships in binding or enzymatic assays, non-linear regression analysis should be performed to determine parameters like Kd, Km, or EC50. Bootstrap resampling provides robust confidence intervals for these parameters. When analyzing time-series data of protein activity, consider repeated measures ANOVA or mixed-effects models that account for temporal correlation.

How can I integrate structural data with functional analyses to understand Bsph_0745's biological role?

Integrating structural and functional data requires a systematic approach to connect Bsph_0745's physical properties with its biological activities. Begin by mapping functional data onto the three-dimensional structure, whether experimentally determined or computationally predicted. Conserved residues identified through multiple sequence alignment should be highlighted on the structural model to identify potential functional sites.

Structure-guided mutagenesis offers a powerful tool for hypothesis testing. Design alanine scanning or site-directed mutations targeting predicted active sites, binding pockets, or protein-protein interaction surfaces. Each mutant should undergo the same functional assays as the wild-type protein, creating a structure-function relationship map. Molecular dynamics simulations can complement experimental data by predicting conformational changes upon ligand binding or protein-protein interactions.

Implement a data integration matrix that correlates structural features (domains, motifs, surface properties) with functional outcomes (binding affinities, enzymatic parameters, in vivo phenotypes). For complex datasets, dimensionality reduction techniques like principal component analysis can identify correlations between structural properties and functional measurements.

Finally, contextualize your findings within the broader biology of L. sphaericus by examining if structural features of Bsph_0745 relate to the bacterium's unique characteristics, such as its inability to metabolize carbohydrates or its insecticidal properties against mosquito larvae .

How might research on Bsph_0745 contribute to understanding the genetic barriers in Lysinibacillus sphaericus?

Research on Bsph_0745 may provide valuable insights into the genetic barriers that make L. sphaericus notoriously difficult to transform. While the LspC3-41I restriction-modification system has been identified as a major determinant for the restriction barrier in strain C3-41 , the potential role of UPF0316 family proteins like Bsph_0745 in genetic regulation remains unexplored. Investigating whether Bsph_0745 interacts with components of R-M systems or participates in DNA metabolism could reveal additional factors affecting genetic accessibility.

Comparative studies examining Bsph_0745 expression levels across strains with different transformation competencies (e.g., comparing naturally transformable strains like 2297 with restriction-proficient strains like C3-41) might uncover correlations between this protein and genetic barrier mechanisms. Knockout studies of Bsph_0745 followed by transformation efficiency assays could directly test its impact on foreign DNA uptake or restriction.

The high genetic conservation observed among mosquitocidal L. sphaericus strains has been hypothesized to result from effective R-M systems that developed after toxin gene acquisition through horizontal gene transfer . Determining if Bsph_0745 contributes to this genomic stability could enhance our understanding of L. sphaericus evolution and provide new strategies for genetic manipulation of this biologically important bacterium.

What experimental approaches could reveal connections between Bsph_0745 and the insecticidal properties of Lysinibacillus sphaericus?

To investigate potential connections between Bsph_0745 and the insecticidal properties of L. sphaericus, implement a comprehensive experimental pipeline beginning with gene expression analysis. Quantitative PCR and RNA-seq comparing Bsph_0745 expression during growth in standard media versus insect hemolymph or during mosquito larval infection could reveal regulation patterns suggestive of involvement in pathogenicity.

Construct knockout and overexpression strains of Bsph_0745 in L. sphaericus and assess their larvicidal activity against mosquito species like Anopheles gambiae and Culex pipiens . Standard bioassays measuring LC50 values and killing speed would quantify changes in insecticidal potency. Histopathological studies examining larval midgut sections after exposure to wild-type versus modified strains might reveal altered toxin binding or epithelial damage patterns.

Protein interaction studies using co-immunoprecipitation and crosslinking followed by mass spectrometry could identify whether Bsph_0745 directly interacts with known insecticidal proteins such as binary toxin (Bin) or Mtx toxins . Additionally, evaluate whether Bsph_0745 affects toxin crystal formation through electron microscopy of sporulating cultures.

The table below outlines a systematic approach to investigating Bsph_0745's potential role in insecticidal activity:

Experimental ApproachKey ParametersExpected Outcomes
Gene expression profilingExpression levels in different growth conditions and during infectionCorrelation between expression and insecticidal activity
Knockout/overexpressionLarvicidal bioassays (LC50, LT50)Quantitative changes in toxicity
Protein-protein interactionCo-IP with known toxins, Y2H screeningIdentification of toxin complex components
Microscopy studiesSpore/crystal formation, larval midgut bindingVisualization of toxin delivery mechanisms
Recombinant co-expressionCombined expression with known toxinsPotential synergistic effects similar to Mtx1/Mtx2

What are the most promising future research directions for understanding UPF0316 family proteins across bacterial species?

Future research on UPF0316 family proteins should pursue several promising directions to elucidate their functions across bacterial species. Comparative genomics represents a foundational approach, analyzing the conservation, genomic context, and evolutionary patterns of UPF0316 proteins across diverse bacteria. Special attention should be paid to differences between pathogenic and non-pathogenic species, potentially revealing roles in virulence or survival.

High-throughput phenotypic screening of UPF0316 knockouts across multiple bacterial species could identify shared phenotypes suggesting conserved functions. This should include stress response assays (oxidative, osmotic, temperature), metabolic profiling, and interaction studies with host cells for pathogenic species. The development of a specialized UPF0316 interactome using techniques like BioID or APEX proximity labeling could map protein neighborhoods across species.

Structural biology approaches, particularly time-resolved crystallography or cryo-EM, might capture conformational changes revealing functional mechanisms. Integrated multi-omics analysis correlating transcriptomic, proteomic, and metabolomic data from UPF0316 mutants could identify altered pathways. Finally, synthetic biology approaches testing functional complementation between UPF0316 homologs from different species would determine functional conservation despite sequence divergence.

The systematic characterization of this protein family would not only illuminate the specific role of Bsph_0745 in L. sphaericus but could also reveal novel bacterial cellular processes with potential applications in biotechnology and medicine.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.